By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Latest World News UpdateLatest World News UpdateLatest World News Update
  • Home
  • Business
  • National
  • Entertainment
  • Sports
  • Health
  • Science
  • Tech
  • World
  • Marathi
  • Hindi
  • Gujarati
  • videos
  • Press Release
    • Press Release
    • Press Release Distribution Packages
  • Live Streaming
  • Legal Talk
Reading: CCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma – World News Network
Share
Notification Show More
Font ResizerAa
Latest World News UpdateLatest World News Update
Font ResizerAa
  • Home
    • Home 1
  • Categories
  • Legal Talk
  • Bookmarks
  • More Foxiz
    • Sitemap
Have an existing account? Sign In
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Latest World News Update > Blog > Business > CCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma – World News Network
Business

CCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma – World News Network

worldnewsnetwork
Last updated: October 2, 2024 12:00 am
worldnewsnetwork 1 year ago
Share
SHARE

New Delhi [India], October 2 (ANI): Competition Commission of India (CCI) has approved the acquisition of Bharat Serums and Vaccines Limited by Mankind Pharma Ltd, the anti-trust regulator said in a statement.
The proposed transaction involves the acquisition of 100 per cent shareholding of Bharat Serums and Vaccines Limited (BSV) by Mankind Pharma Ltd (Mankind).
Mankind is a public listed company and is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical finished dosage formulations (FDFs) across various acute and chronic therapeutic areas, as well as several consumer healthcare products such as condoms, emergency contraceptives, pregnancy tests, vitamins, minerals, nutrients, antacids and anti-acne preparations segments.
Through its subsidiaries, Mankind is also engaged in, inter alia, the manufacture and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediaries, and packaging products for pharmaceutical products.
BSV, along with its subsidiaries, is engaged in research, development, licensing, manufacturing, importing, exporting, marketing and distribution of: FDFs and APIs; biotech and biological formulations and/or API; food and health supplements; medical devices; and ayurvedic medicines; in each case, in the therapeutic areas such as gynaecology, in-vitro fertilisation, critical care and/or emergency medicines for human use.
In India, the activities of BSV (including its wholly owned Indian subsidiary, BSV Pharma Private Limited, which is in the process of merging with BSV) are limited to developing, manufacturing, and marketing a range of biological, biotech, and pharmaceutical products in the therapeutic areas of women’s health, critical care, IUI-IVF, and emergency medicine. (ANI)

Contents
WORLD MEDIA NETWORKPRESS RELEASE DISTRIBUTIONPress releases distribution in 166 countriesPress releases in all languagesPress releases in Indian LanguagesIndia PackagesEurope PackagesAsia PackagesMiddle East & Africa PackagesSouth America PackagesUSA & Canada PackagesOceania PackagesCis Countries PackagesWorld Packages

Disclaimer: This story is auto-generated from a syndicated feed of ANI; only the image & headline may have been reworked by News Services Division of World News Network Inc Ltd and Palghar News and Pune News and World News

sponsored by

WORLD MEDIA NETWORK


PRESS RELEASE DISTRIBUTION

Press releases distribution in 166 countries

EUROPE UK, INDIA, MIDDLE EAST, AFRICA, FRANCE, NETHERLANDS, BELGIUM, ITALY, SPAIN, GERMANY, AUSTRIA, SWITZERLAND, SOUTHEAST ASIA, JAPAN, SOUTH KOREA, GREATER CHINA, VIETNAM, THAILAND, INDONESIA, MALAYSIA, SOUTH AMERICA, RUSSIA, CIS COUNTRIES, AUSTRALIA, NEW ZEALAND AND MORE

Press releases in all languages

ENGLISH, GERMAN, DUTCH, FRENCH, PORTUGUESE, ARABIC, JAPANESE, and KOREAN CHINESE, VIETNAMESE, INDONESIAN, THAI, MALAY, RUSSIAN. ITALIAN, SPANISH AND AFRICAN LANGUAGES

Press releases in Indian Languages

HINDI, MARATHI, GUJARATI, TAMIL, TELUGU, BENGALI, KANNADA, ORIYA, PUNJABI, URDU, MALAYALAM
For more details and packages

Email - support@worldmedianetwork.uk
Website - worldmedianetwork.uk

India Packages

Read More

Europe Packages

Read More

Asia Packages

Read More

Middle East & Africa Packages

Read More

South America Packages

Read More

USA & Canada Packages

Read More

Oceania Packages

Read More

Cis Countries Packages

Read More

World Packages

Read More
sponsored by

You Might Also Like

Goldman Sachs sees Nifty at 29,000 by end-2026, expects 14% upside on growth revival and strong earnings outlook – World News Network

Latest Economy Observer from Dun & Bradstreet highlights: India Navigating Unprecedented Global Policy Uncertainty with Economic Resilience – World News Network

Lehar Footwears announced H1FY26 and Q2FY26 results, Reports Strong Revenue and PAT Growth – World News Network

Former Prasar Bharati CEO Shashi Shekhar Vempati joins board of BharatGen Technology Foundation as Independent Director – World News Network

Driving India’s geospatial revolution: MapmyIndia Mappls partners with Survey of India and IOCL – World News Network

Share This Article
Facebook Twitter Email Print
Previous Article REC signs MoU to provide Rs 3 lakh crore for Rajasthan infra projects by 2030 – World News Network
Next Article Andhra Pradesh: YSRCP criticises new excise policy – World News Network
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright © 2024 World News Network. All Rights Reserved.
  • Advertise with us
  • Newsletters
  • Deal
Welcome Back!

Sign in to your account

Lost your password?